Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Decoding the CLOSURE-AF trial: new insights and a call for critical review.

Created on 19 Nov 2026

Authors

Philippe Garot, Jens Erik Nielsen-Kudsk, Ole De Backer

Published in

European heart journal. Valvular and structural heart disease. Volume 2. Issue 3. Pages xwag049. Epub Jun 18, 2026.

Abstract

Graphical AbstractA critical review of the CLOSURE-AF trial and lessons learned. Concerns about patient selection (bias), procedural safety and post-procedural medical therapy are raised. The CLOSURE-AF trial mainly enrolled high-risk, multi-morbid patients, for whom LAAC did not yield net clinical benefit compared with OAC therapy. LAAC, left atrial appendage closure; OAC, oral anticoagulant.For image description, please refer to the figure legend and surrounding text.

PMID:
43053895
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement